Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes. While studying molecular interactions has been a research focus for many years and has provided important insight into biology, the attention has now shifted towards a more integrative network biology approach.
Our Partners
British Heart Foundation
Queen Mary University of London
University of Oxford
FFG
MUI, Medizinischen Universität Innsbruck
UKE Hamburg
University Medicine Göttingen
UKD Dusseldorf
Mount Sinai
CARIM Maastricht
Group lead
British Heart Foundation Professor of Cardiovascular Proteomics